Curcumin and cardiovascular diseases: Focus on cellular targets and cascades

Biomed Pharmacother. 2021 Apr:136:111214. doi: 10.1016/j.biopha.2020.111214. Epub 2021 Jan 12.

Abstract

Cardiovascular diseases (CVDs) are one of the leading causes of the most considerable mortality globally, and it has been tried to find the molecular mechanisms and design new drugs that triggered the molecular target. Curcumin is the main ingredient of Curcuma longa (turmeric) that has been used in traditional medicine for treating several diseases for years. Numerous investigations have indicated the beneficial effect of Curcumin in modulating multiple signaling pathways involved in oxidative stress, inflammation, apoptosis, and proliferation. The cardiovascular protective effects of Curcumin against CVDs have been indicated in several studies. In the current review study, we provided novel information on Curcumin's protective effects against various CVDs and potential molecular signaling targets of Curcumin. Nonetheless, more studies should be performed to discover the exact molecular target of Curcumin against CVDs.

Keywords: Cardiovascular diseases; Curcumin; Molecular signaling.

Publication types

  • Review

MeSH terms

  • Animals
  • Cardiovascular Agents / therapeutic use*
  • Cardiovascular Diseases / drug therapy*
  • Cardiovascular Diseases / metabolism
  • Cardiovascular Diseases / physiopathology
  • Cardiovascular System / drug effects*
  • Cardiovascular System / metabolism
  • Cardiovascular System / physiopathology
  • Curcumin / therapeutic use*
  • Humans
  • Molecular Targeted Therapy
  • Signal Transduction / drug effects*

Substances

  • Cardiovascular Agents
  • Curcumin